Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 28;8(56):95791-95798.
doi: 10.18632/oncotarget.21327. eCollection 2017 Nov 10.

Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx

Affiliations

Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx

Filippo Ricciardiello et al. Oncotarget. .

Abstract

Basaloid squamous cell carcinoma (BSCC) is a rare, aggressive and distinct variant of squamous cell carcinoma (SCC) of the upper respiratory and digestive tract. We have evaluated disease specific survival (DSS) and overall survival (OS) through Kaplan-Meier method and mortality risk through univariate statistical analysis of Cox in 42 cases of BSCC and other 42 of laryngeal SCC (LSCC) matched for both age and sex. We demonstrated that laryngeal BSCC is a more aggressive tumor than LSCC as is associated to higher nodal recurrence of pathology (5 vs 2 patients, overall risk, OR 2.7), a reduced survival (median survival 34 vs 40 months, OR 3.2 for mortality); in addition, basaloid patients have a higher risk to be affected by second primary tumors (13 vs 3 patients, OR 5.8) and a higher probability to die for this second tumor (Hazard Risk, HR 4.4). The analysis of survival shows an increased mortality risk concurrent with the parameters assessed by univariate analyses that assume a predictive and statistical significance in second tumor and grading in basaloid LSSC.

Keywords: laryngea lbasaloid squamocellular carcinoma (BSCC); loco-regional recurrence in laryngeal BSCC; mortality of laryngeal BSCC; prognosis of laryngeal basaloid squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare they have no known conflicts of interest in this work.

Figures

Figure 1
Figure 1
Survival rate analysis in basaloid subgroup A (A); in non-basaloid subgroup B (B); disease specific survival comparison between two subgroups (C).
Figure 2
Figure 2
OS in basaloid A and non-basaloid B subgroups (A); survival probability in relation to follow-up period in months in basaloid subgroup B (B).

References

    1. Alkan S, Uslu Coskun B, Ugur S, Basak T, Dadas B. Basaloid squamous cell carcinoma of the larynx. Auris Nasus Larynx. 2006(33):71–74. - PubMed
    1. Erdamar B, Souglu Y, Sirin M, Karatay C, Katircioglu S, Kiyak E. Basaloid squamous cell carcinoma of the supraglottic larynx. Eur Arch Ororhinolaryngol. 2000(257):154–157. - PubMed
    1. Zbaren P, Nuyens M, Stauffer E. Basaloid squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2004(12):116–121. - PubMed
    1. Soprani F, Armaroli V, Stefanelli A, Emiliani E, Padovani D, Casolino D. Basaloid squamous cell carcinoma of the larynx: report of a early laryngeal cancer. Acta Otorhinolaryngol Ital. 2011(31):181–5. - PMC - PubMed
    1. Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol. 1996(105):75–82. - PubMed